BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 2191502)

  • 1. Current status of renal transplantation.
    Suranyi MG; Hall BM
    West J Med; 1990 Jun; 152(6):687-96. PubMed ID: 2191502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Bergamo Kidney Transplant Program.
    Perico N; Cravedi P; Ruggenenti P; Gotti E; Rota G; Locatelli G; Gambara V; Perna A; Rota S; Remuzzi G
    Clin Transpl; 2005; ():85-100. PubMed ID: 17424727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic renal allograft failure: clinical overview. The Leuven Collaborative Group for Transplantation.
    Peeters J; Roels L; Vanrenterghem Y
    Kidney Int Suppl; 1995 Dec; 52():S97-101. PubMed ID: 8587294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants.
    Cecka JM
    Clin Transpl; 1997; ():1-14. PubMed ID: 9919387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunosuppressive agents in pediatric renal transplantation].
    Ismaili K; Abramowicz D; Adams B; Godefroid N; Lolin K; Schurmans T; Hall M; Janssen F
    Rev Med Brux; 2005; 26(6):505-12. PubMed ID: 16454154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunopharmacologic therapy in renal transplantation.
    Shoker AS
    Pharmacotherapy; 1996; 16(4):562-75. PubMed ID: 8840362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation 1994: the year in review.
    Browne BJ; Kahan BD
    Clin Transpl; 1994; ():317-40. PubMed ID: 7547552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of ethnicity, donor status and HLA matching on renal allograft survival: a single center study.
    Chelluri LK; Vasantha A; Ratnakar KS
    Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):995-7. PubMed ID: 19861859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive strategies to improve outcomes of kidney transplantation.
    Tang IY; Meier-Kriesche HU; Kaplan B
    Semin Nephrol; 2007 Jul; 27(4):377-92. PubMed ID: 17616271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney transplantation, the Halifax experience.
    Belitsky P; MacDonald AS; Lawen J; McAlister V; Bitter-Suermann H; Kiberd B; West K; Sketris I
    Clin Transpl; 1996; ():231-40. PubMed ID: 9286572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The LifeLink Foundation and cadaver kidney transplantation in Tampa.
    LeFor WM; Wright CE; Bowers VD; Heinrichs DF; Shires DL
    Clin Transpl; 1999; ():149-58. PubMed ID: 11038633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical complications and renal function after kidney alone or simultaneous pancreas-kidney transplantation: a matched comparative study.
    Gutiérrez P; Marrero D; Hernández D; Vivancos S; Pérez-Tamajón L; Rodríguez de Vera JM; Alarcó A; González-Posada JM
    Nephrol Dial Transplant; 2007 May; 22(5):1451-5. PubMed ID: 17327283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive standards in simultaneous kidney-pancreas transplantation.
    Schmied BM; Müller SA; Mehrabi A; Welsch T; Büchler MW; Zeier M; Schmidt J
    Clin Transplant; 2006; 20 Suppl 17():44-50. PubMed ID: 17100700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal transplantation in cyclosporine-treated recipients at the Singapore General Hospital.
    Vathsala A; Woo KT
    Clin Transpl; 1999; ():189-97. PubMed ID: 11038637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renal transplantation in adult].
    Legendre C
    Rev Prat; 2012 Jan; 62(1):65-71. PubMed ID: 22335070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of race and ethnicity on kidney allograft outcome.
    Katznelson S; Gjertson DW; Cecka JM
    Clin Transpl; 1995; ():379-94. PubMed ID: 8794281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daclizumab is associated with decreased rejection and improved patient survival in renal transplant recipients.
    Morris JA; Hanson JE; Steffen BJ; Chu AH; Chi-Burris KS; Gotz VP; Gordon RD
    Clin Transplant; 2005 Jun; 19(3):340-5. PubMed ID: 15877795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing long-term outcomes following renal transplantation: a review.
    Shrestha BM; Haylor JL
    JNMA J Nepal Med Assoc; 2007; 46(167):136-42. PubMed ID: 18274571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.